Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL von Woyach, Jennifer A, Ruppert, Amy S, Heerema, Nyla A, Zhao, Weiqiang, Booth, Allison M, Ding, Wei, Bartlett, Nancy L, Brander, Danielle M, Barr, Paul M, Rogers, Kerry A, Parikh, Sameer A, Coutre, Steven, Hurria, Arti, Brown, Jennifer R, Lozanski, Gerard, Blachly, James S, Ozer, Hatice G, Major-Elechi, Brittny, Fruth, Briant, Nattam, Sreenivasa, Larson, Richard A, Erba, Harry, Litzow, Mark, Owen, Carolyn, Kuzma, Charles, Abramson, Jeremy S, Little, Richard F, Smith, Scott E, Stone, Richard M, Mandrekar, Sumithra J, Byrd, John C

Volltext

Management of chronic lymphocytic leukemia (CLL) in the elderly: a position paper from an international Society of Geriatric Oncology (SIOG) Task Force von Stauder, R., Eichhorst, B., Hamaker, M.E., Kaplanov, K., Morrison, V.A., Österborg, A., Poddubnaya, I., Woyach, J.A., Shanafelt, T., Smolej, L., Ysebaert, L., Goede, V.

Volltext

Incidence and description of autoimmune cytopenias during treatment with ibrutinib for chronic lymphocytic leukemia von Rogers, K A, Ruppert, A S, Bingman, A, Andritsos, L A, Awan, F T, Blum, K A, Flynn, J M, Jaglowski, S M, Lozanski, G, Maddocks, K J, Byrd, J C, Woyach, J A, Jones, J A

Volltext

Application of a sequential multiple assignment randomized trial (SMART) design in older patients with chronic lymphocytic leukemia von Ruppert, A.S., Yin, J., Davidian, M., Tsiatis, A.A., Byrd, J.C., Woyach, J.A., Mandrekar, S.J.

Volltext

Outcome of patients with relapsed or refractory chronic lymphocytic leukemia treated with flavopiridol: impact of genetic features von Woyach, J A, Lozanski, G, Ruppert, A S, Lozanski, A, Blum, K A, Jones, J A, Flynn, J M, Johnson, A J, Grever, M R, Heerema, N A, Byrd, J C

Volltext

Risk factors for tumor lysis syndrome in patients with chronic lymphocytic leukemia treated with the cyclin-dependent kinase inhibitor, flavopiridol von Blum, K A, Ruppert, A S, Woyach, J A, Jones, J A, Andritsos, L, Flynn, J M, Rovin, B, Villalona-Calero, M, Ji, J, Phelps, M, Johnson, A J, Grever, M R, Byrd, J C

Volltext

A phase I/II study of rituximab and etanercept in patients with chronic lymphocytic leukemia and small lymphocytic lymphoma von Woyach, J A, Lin, T S, Lucas, M S, Heerema, N, Moran, M E, Cheney, C, Lucas, D M, Wei, L, Caligiuri, M A, Byrd, J C

Volltext

PF377 ACALABRUTINIB WITH OBINUTUZUMAB IN TREATMENT‐NAIVE AND RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA: 3‐YEAR FOLLOW‐UP von Woyach, J.A., Rogers, K., Bhat, S., Blachly, J., Jianfar, M., Frigault, M.M., Hamdy, A., Izumi, R., Munugalavadla, V., Quah, C., Wang, M.H., Byrd, J.C.

Volltext

Supplementary Material for: Safety of extended pirtobrutinib exposure in relapsed and/or refractory B-cell malignancies von L.E., Roeker, C.C., Coombs, N.N., Shah, W., Jurczak, J.A., Woyach, C.Y., Cheah, K., Patel, K., Maddocks, Y., Wang, P.L., Zinzani, T., Munir, Y., Koh, M.C., Thompson, C.E., Muehlenbein, C., Wang, R., Sizelove, S., Abhyankar, S., Hasanabba, D.E., Tsai, T.A., Eyre, M., Wang

Volltext bestellen

Incidence and description of autoimmune cytopenias during treatment with ibrutinib for chronic lymphocytic leukemia von Rogers, K.A, Ruppert, A.S, Bingman, A, Andritsos, L.A, Awan, F.T, Blum, K.A, Flynn, J.M, Jaglowski, S.M, Lozanski, G, Maddocks, K.J, Byrd, J.C, Woyach, J.A, Jones, J.A

Volltext

Outcome of patients with relapsed or refractory chronic lymphocytic leukemia treated with flavopiridol: impact of genetic features von Woyach, J.A, Lozanski, G, Ruppert, A.S, Lozanski, A, Blum, K.A, Jones, J.A, Flynn, J.M, Johnson, A.J, Grever, M.R, Heerema, N.A, Byrd, J.C

Volltext

A phase I/II study of rituximab and etanercept in patients with chronic lymphocytic leukemia and small lymphocytic lymphoma von Woyach, J.A, Lin, T.S, Lucas, M.S, Heerema, N, Moran, M.E, Cheney, C, Lucas, D.M, Wei, L, Caligiuri, M.A, Byrd, J.C

Volltext

Risk factors for tumor lysis syndrome in patients with chronic lymphocytic leukemia treated with the cyclin-dependent kinase inhibitor, flavopiridol von Blum, K.A, Ruppert, A.S, Woyach, J.A, Jones, JA, Andritsos, L, Flynn, J.M, Rovin, B, Villalona-Calero, M, Ji, J, Phelps, M, Johnson, A.J, Grever, M.R, Byrd, J.C

Volltext

Impact of targeted therapy on outcome of chronic lymphocytic leukemia patients with relapsed del(17p13.1) karyotype at a single center von Stephens, D M, Ruppert, A S, Jones, J A, Woyach, J, Maddocks, K, Jaglowski, S M, Andritsos, L A, Flynn, J M, Grever, M R, Lozanski, G, Johnson, A J, Muthusamy, N, Heerema, N A, Byrd, J C

Volltext